Loading...
Loading...
India accounts for a significant share of global Mitoxantrone exports, with 42+ registered manufacturers shipping to buyers across 35+ countries — yet a handful of companies dominate the shipments. INTAS PHARMACEUTICALS LIMITED holds the largest share at 37.1% (export value: $700.0K). Close behind, SP ACCURE LABS PRIVATE LIMITED (3.7%, $69.8K). MEDWISE OVERSEAS PRIVATE LIMITED (3.0%, $57.4K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
Comprehensive supplier network intelligence dashboard
Flow of Mitoxantrone from leading Indian exporters to their key global customers
Top Suppliers → Customer Networks
The Mitoxantrone export market from India is led by INTAS PHARMACEUTICALS LIMITED, which alone commands a 37.1% share, shipping $700.0K worth of product across 13 shipments. The second-largest exporter, SP ACCURE LABS PRIVATE LIMITED, contributes $69.8K (3.7%) to the overall market. Combined, the top two suppliers alone account for 40.8% of all Mitoxantrone exports, indicating a relatively concentrated supply base.
Across all 42 tracked manufacturers, the total Mitoxantrone export value stands at $1.9M from 110 shipments. The market average shipment value is $17.2K. The single largest buyer relationship in terms of trade value is ACCORD FARMA S.A.DE C.V, receiving $319.7K worth of product.
The combined buyer network spans 5 named purchasing companies, including ACCORD FARMA S.A.DE C.V, ALLOGA FRANCE, SITE D#AMIENS, HERNG SHAN CO., LTD., PHARMACIE CENTRALE D. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
INTAS PHARMACEUTICALS LIMITED is the first-largest Mitoxantrone exporter from India, with a market share of 37.1% and a total export value of $700.0K across 13 shipments. Their average shipment value of $53.8K is above the market average of $17.2K, suggesting premium or bulk contract pricing.
INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• ACCORD FARMA S.A.DE C.V — $319.7K across 6 shipments (45.7% of this supplier's total exports)
• TO THE ORDER. — $265.2K across 5 shipments (37.9% of this supplier's total exports)
• ALLOGA FRANCE — $94.2K across 2 shipments (13.5% of this supplier's total exports)
• SITE D#AMIENS — $19.6K across 0 shipments (2.8% of this supplier's total exports)
• TO THE ORDER. — $1.4K across 0 shipments (0.2% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED's per-shipment value of $53.8K is 214% above the market average of $17.2K, consistent with large-order contracts or value-added formulations.
SP ACCURE LABS PRIVATE LIMITED is the second-largest Mitoxantrone exporter from India, with a market share of and a total export value of across . Their average shipment value of is
Once Mitoxantrone leaves the manufacturing plants of companies like INTAS PHARMACEUTICALS LIMITED and SP ACCURE LABS PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $1.9M. Namibia absorbs the largest share at 47.0% ($887.6K), followed by Mexico (31.0%) and Venezuela (4.1%).
In Namibia — the top destination — named importers include SALUTEM MEDICAL (PTY) LTD. In Mexico, key buyers are ACCORD FARMA S.A.DE C.V.
This geographic spread reflects Mitoxantrone's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
Comprehensive geographic market intelligence dashboard
Trade flow of Mitoxantrone exports from India — top destination countries and the named companies importing it
Top Countries → Global Importers
Namibia ranks as the first-largest destination for Mitoxantrone imports from India, with a total trade value of $887.6K across 3 shipments — representing a 47.0% share of all Mitoxantrone exports. The average shipment value of $295.9K is above the global average of $17.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Mitoxantrone importers in Namibia: SALUTEM MEDICAL (PTY) LTD is the largest buyer, accounting for 100.0% ($887.6K) of this market's total imports.
• SALUTEM MEDICAL (PTY) LTD — $887.6K (100.0% of Namibia's total)
Key Insight: Namibia's per-shipment average of $295.9K (1624% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Namibia is a key market for Mitoxantrone imports from India.
Mexico ranks as the second-largest destination for Mitoxantrone imports from India, with a total trade value of $585.1K across — representing a share of all Mitoxantrone exports. The average shipment value of is
Latest developments and market context
Detailed market intelligence for Mitoxantrone — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
SP ACCURE LABS PRIVATE LIMITED serves 1 named buyer in our database. HERNG SHAN CO., LTD. is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• HERNG SHAN CO., LTD. — $69.8K across 3 shipments (100.0% of this supplier's total exports)
Key Insight: SP ACCURE LABS PRIVATE LIMITED's per-shipment value of $23.3K is 36% above the market average of $17.2K, consistent with large-order contracts or value-added formulations.
MEDWISE OVERSEAS PRIVATE LIMITED is the third-largest Mitoxantrone exporter from India, with a market share of 3.0% and a total export value of $57.4K across 3 shipments. Their average shipment value of $19.1K is above the market average of $17.2K, suggesting premium or bulk contract pricing.
MEDWISE OVERSEAS PRIVATE LIMITED serves 1 named buyer in our database. TO is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• TO — $57.4K across 3 shipments (100.0% of this supplier's total exports)
Key Insight: MEDWISE OVERSEAS PRIVATE LIMITED's per-shipment value of $19.1K is 11% above the market average of $17.2K, consistent with large-order contracts or value-added formulations.
NEON LABORATORIES LIMITED is the fourth-largest Mitoxantrone exporter from India, with a market share of 0.1% and a total export value of $2.4K across 3 shipments. Their average shipment value of $800 is below the market average of $17.2K, reflecting a high-volume, competitive pricing strategy.
NEON LABORATORIES LIMITED serves 1 named buyer in our database. PHARMACIE CENTRALE D is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• PHARMACIE CENTRALE D — $2.4K across 3 shipments (100.0% of this supplier's total exports)
Key Insight: NEON LABORATORIES LIMITED operates with high shipment frequency (3 shipments) at a per-shipment value of $800, indicating a broad distribution network with many smaller, regular orders.
MVL GLOBAL is the fifth-largest Mitoxantrone exporter from India, with a market share of 0.0% and a total export value of $0 across 3 shipments. Their average shipment value of $0 is below the market average of $17.2K, reflecting a high-volume, competitive pricing strategy.
Key Insight: MVL GLOBAL operates with high shipment frequency (3 shipments) at a per-shipment value of $0, indicating a broad distribution network with many smaller, regular orders.
CHANDRA BHAGAT PHARMA LIMITED is the fifth-largest Mitoxantrone exporter from India, with a market share of 0.0% and a total export value of $0 across 5 shipments. Their average shipment value of $0 is below the market average of $17.2K, reflecting a high-volume, competitive pricing strategy.
Key Insight: CHANDRA BHAGAT PHARMA LIMITED operates with high shipment frequency (5 shipments) at a per-shipment value of $0, indicating a broad distribution network with many smaller, regular orders.
Named Mitoxantrone importers in Mexico: ACCORD FARMA S.A.DE C.V is the largest buyer, accounting for 54.6% ($319.7K) of this market's total imports.
• ACCORD FARMA S.A.DE C.V — $319.7K (54.6% of Mexico's total)
Key Insight: Mexico's per-shipment average of $292.6K (1605% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Mexico is a key market for Mitoxantrone imports from India.
Venezuela ranks as the third-largest destination for Mitoxantrone imports from India, with a total trade value of $77.4K across 0 shipments — representing a 4.1% share of all Mitoxantrone exports. The average shipment value of $77.4K is above the global average of $17.2K, indicating high-value procurement contracts or branded formulations.
Key Insight: Venezuela's per-shipment average of $77.4K (351% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Venezuela is a key market for Mitoxantrone imports from India.
Netherlands ranks as the fourth-largest destination for Mitoxantrone imports from India, with a total trade value of $72.5K across 0 shipments — representing a 3.8% share of all Mitoxantrone exports. The average shipment value of $72.5K is above the global average of $17.2K, indicating high-value procurement contracts or branded formulations.
Key Insight: Netherlands's per-shipment average of $72.5K (322% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Netherlands is a key market for Mitoxantrone imports from India.
Taiwan ranks as the fifth-largest destination for Mitoxantrone imports from India, with a total trade value of $69.8K across 2 shipments — representing a 3.7% share of all Mitoxantrone exports. The average shipment value of $34.9K is above the global average of $17.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Mitoxantrone importers in Taiwan: HERNG SHAN CO., LTD. is the largest buyer, accounting for 100.0% ($69.8K) of this market's total imports.
• HERNG SHAN CO., LTD. — $69.8K (100.0% of Taiwan's total)
Key Insight: Taiwan's per-shipment average of $34.9K (103% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Taiwan is a key market for Mitoxantrone imports from India.
Top supplier: 5 customers
6 suppliers → 35 countries
Network value: $1.9M
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
110 Verified Shipments
42 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists